CytomX Therapeutics, Inc. (CTMX)

NASDAQ: CTMX · Real-Time Price · USD

4.680

-0.090 (-1.89%)

At close: Mar 6, 2026, 4:00 PM EST

4.641

-0.039 (-0.84%)

After-hours: Mar 6, 2026, 7:40 PM EST

CytomX Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	113.63	138.1	101.21	53.16	37.31	68.43
Revenue Growth (YoY)	-10.26%	36.45%	90.38%	42.48%	-45.47%	154.36%
Gross Profit	113.63	138.1	101.21	53.16	37.31	68.43
Selling, General & Admin	28.1	29.73	30.02	42.85	39.16	36.03
Research & Development	62.28	83.38	77.68	111.65	114.19	112.94
Total Operating Expenses	90.39	113.11	107.7	154.5	153.35	148.97
Operating Income	23.25	25	-6.48	-101.34	-116.04	-80.54
Interest Income	5	7.14	9.84	1.68	0.26	1.84
Other Non-Operating Income (Expense)	0.01	-0.04	-0.03	0.34	-0.08	-0.03
Total Non-Operating Income (Expense)	5.02	7.1	9.81	2.02	0.17	1.81
Pretax Income	28.26	32.09	3.32	-99.32	-115.87	-78.73
Provision for Income Taxes	0.25	0.22	3.89	-	-	-13.91
Net Income	28.02	31.87	-0.57	-99.32	-115.87	-64.82
Net Income to Common	28.02	31.87	-0.57	-99.32	-115.87	-64.82
Net Income Growth	102.59%	-	-	-	-	-
Shares Outstanding (Basic)	117	84	74	66	64	46
Shares Outstanding (Diluted)	117	85	74	66	64	46
Shares Change (YoY)	39.68%	14.82%	12.27%	2.48%	39.01%	1.79%
EPS (Basic)	0.41	0.38	-0.01	-1.51	-1.81	-1.40
EPS (Diluted)	0.41	0.38	-0.01	-1.51	-1.81	-1.40
EPS Growth	141.18%	-	-	-	-	-
Free Cash Flow	-72.35	-86.54	-56.88	-112.53	-120.64	2.95
Free Cash Flow Per Share	-0.62	-1.02	-0.77	-1.71	-1.88	0.06
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	20.46%	18.10%	-6.41%	-190.61%	-311.00%	-117.70%
Profit Margin	24.66%	23.08%	-0.56%	-186.82%	-310.54%	-94.73%
FCF Margin	-63.67%	-62.66%	-56.19%	-211.67%	-323.33%	4.31%
EBITDA	24.53	26.76	-4.31	-98.89	-113.34	-77.97
EBITDA Margin	21.58%	19.38%	-4.26%	-186.02%	-303.75%	-113.94%
EBIT	23.25	25	-6.48	-101.34	-116.04	-80.54
EBIT Margin	20.46%	18.10%	-6.41%	-190.61%	-311.00%	-117.70%
Effective Tax Rate	0.87%	0.70%	117.12%	0.00%	0.00%	17.67%

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q